Rodilla Enrique, Molinero Ana, Gijón-Conde Teresa, Tous Salvador, Fornós José A, Mera Inés, Martínez Fernando, Carreras Blanca, de Berardinis Bettina, Beaney Thomas, Ster Anca Chis, Poulter Neil R, Xia Xin, Ruilope Luis M
Internal Medicine, University Hospital Sagunto, Universidad Cardenal Herrera-CEU, CEU Universities, Calle Luis Vives, 1 Alfara del Patriarca, Valencia 46115, Spain.
Spanish Society of Community and Family Pharmacy, Paseo de las Delicias, 31 - Esc. Izq. 4º Dcha., Madrid 28045, Spain.
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H119-H121. doi: 10.1093/eurheartj/suaa044. Epub 2020 Aug 28.
Elevated blood pressure (BP) is the single most important contributing risk factor to the global disease burden, leading to over 10 million deaths each year. In Spain, hypertension (HTN) affects around 20% of the adult population and remains the greatest attributable cause of cardiovascular mortality. May Measurement Month (MMM) is a worldwide initiative aimed at increasing awareness of HTN and to improve the lack of screening programmes worldwide. An opportunistic cross-sectional survey of volunteers aged 18 and over was carried out in May 2018. Blood pressure measurement, the definition of HTN and statistical analysis followed the standard MMM protocol. Anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors were obtained as additional information. Screening sites mainly in community pharmacies, universities, primary care centres, HTN units, and cardiovascular departments in hospitals were set up across Spain as part of this initiative. In total, 7646 individuals (63.5% female) were screened during MMM18. After multiple imputation, 40.0% had HTN, of whom 74.4% were aware of their diagnosis and 69.6% were taking antihypertensive medication. Of individuals not receiving antihypertensive medication, 16.9% were hypertensive. Of individuals receiving antihypertensive medication, 36.4% had uncontrolled BP. MMM18 almost doubled the number of participants of MMM17 and was the largest BP screening campaign ever undertaken in Spain, showing that in the absence of systematic screening programmes for HTN, MMM can identify a great number of individuals at risk, increasing their awareness and attracting the interest of the healthcare system in Spain.
血压升高是导致全球疾病负担的最重要单一风险因素，每年导致超过1000万人死亡。在西班牙，高血压影响着约20%的成年人口，仍然是心血管疾病死亡的最大可归因原因。五月测量月（MMM）是一项全球倡议，旨在提高对高血压的认识，并改善全球筛查项目的不足。2018年5月对18岁及以上的志愿者进行了一项机会性横断面调查。血压测量、高血压的定义和统计分析遵循标准的MMM方案。获取人体测量数据以及关于人口统计学、生活方式和环境因素的问卷答复作为补充信息。作为该倡议的一部分，在西班牙各地设立了主要位于社区药房、大学、初级保健中心、高血压科室和医院心血管科的筛查点。在MMM18期间，总共对7646人（63.5%为女性）进行了筛查。经过多重插补后，40.0%的人患有高血压，其中74.4%的人知晓自己的诊断，69.6%的人正在服用抗高血压药物。在未服用抗高血压药物的个体中，16.9%患有高血压。在服用抗高血压药物的个体中，36.4%的人血压未得到控制。MMM18的参与者人数几乎是MMM17的两倍，是西班牙有史以来规模最大的血压筛查活动，表明在缺乏系统性高血压筛查项目的情况下，MMM可以识别大量有风险的个体，提高他们的认识，并吸引西班牙医疗系统的关注。
